<DOC>
	<DOCNO>NCT01781728</DOCNO>
	<brief_summary>The investigator look see certain dose stereotactic body radiation therapy ( SBRT ) may viable treatment option recurrent residual pancreatic periampullary adenocarcinoma .</brief_summary>
	<brief_title>Palliative Stereotactic Radiation Pancreatic Periampullary Adenocarcinoma</brief_title>
	<detailed_description>No standard treatment option yet establish patient recurrent residual disease definitive treatment pancreatic periampullary cancer ( duodenal , ampullary , bile duct ) . Linac base stereotactic body radiation therapy ( SBRT ) administer 1-3 fraction show effective treatment option patient unresectable , locally advanced pancreatic adenocarcinoma , achieve local control rate 84-92 % one year . Associated late gastrointestinal toxicity rate report 22-25 % 1 year . We hypothesize similarly excellent local control rate ( 80-90 % one year ) reasonable rate toxicity ( ≤20 % ) achieve use Linac base SBRT deliver 5 Gy x 5 patient local failure ( remain disease ) previous treatment conventional chemoradiation therapy ( CRT ) without surgery 6.6 Gy x 5 radiation-naïve patient local failure ( remain disease ) previous treatment surgery and/or chemotherapy . The toxicity note trial grade 2 great gastritis , fistula , enteritis , ulcer , grade 3 great gastrointestinal toxicity .</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>18 year age old Karnofsky Performance Status great equal 70 % confirm pancreatic periampullary adenocarcinoma pancreatic periampullary tumor le 8.0 cm great axial dimension Either : standard care treatment pancreatic cancer include radiation therapy * patient may receive continue chemotherapy post initial CRT . standard care treatment pancreatic cancer include radiation therapy * patient must attempt chemotherapy upon initial diagnosis acceptable organ marrow function determine blood test ability understand give consent must patient treated SBRT Johns Hopkins Hospital life expectancy great 3 month extensive metastatic disease performance status le 70 child exclude form study uncontrolled intercurrent illness concurrent malignancy melanoma pregnant breast feed woman exclude woman postmenopausal positive pregnancy test life expectancy le 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>recurrent</keyword>
	<keyword>unresectable</keyword>
	<keyword>residual</keyword>
	<keyword>stereotactic body radiation therapy ( SBRT )</keyword>
	<keyword>palliative management</keyword>
</DOC>